0001062993-20-004521.txt : 20200916
0001062993-20-004521.hdr.sgml : 20200916
20200916161914
ACCESSION NUMBER: 0001062993-20-004521
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200915
FILED AS OF DATE: 20200916
DATE AS OF CHANGE: 20200916
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sklawer Andrew D
CENTRAL INDEX KEY: 0001782334
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21088
FILM NUMBER: 201179064
MAIL ADDRESS:
STREET 1: 5777 CENTRAL AVENUE, SUITE 102
CITY: BOULDER
STATE: CO
ZIP: 80301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Brickell Biotech, Inc.
CENTRAL INDEX KEY: 0000819050
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 930948554
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5777 CENTRAL AVENUE
STREET 2: SUITE 102
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: (720) 505-4755
MAIL ADDRESS:
STREET 1: 5777 CENTRAL AVENUE
STREET 2: SUITE 102
CITY: BOULDER
STATE: CO
ZIP: 80301
FORMER COMPANY:
FORMER CONFORMED NAME: VICAL INC
DATE OF NAME CHANGE: 19940211
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2020-09-15
0000819050
Brickell Biotech, Inc.
BBI
0001782334
Sklawer Andrew D
C/O BRICKELL BIOTECH, INC.
5777 CENTRAL AVENUE, SUITE 102
BOULDER
CO
80301
0
1
0
0
COO and Secretary
Stock Option (right to buy)
.80
2020-09-15
4
A
0
450000
0
A
2030-09-15
Common Stock
450000
450000
D
The stock options will vest 25% on September 15, 2021, and the remainder will vest in equal monthly installments over the following three years.
/s/ Christine G. Long, Attorney-in-Fact for Andrew Sklawer (power of attorney previously filed)
2020-09-16